Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Find out what happened in the markets today – and why you should care – with the free Daily Brief newsletter. Dr Lal Path Labs is tapping into the increasing health awareness among consumers, ...

Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is ...

(Reuters) – India’s Dr Lal Path Labs reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3% higher. The company’s ...

New Delhi: India's Dr Lal Path Labs reported a 19per cent jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3per cent higher.

Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 23,919.47 Crore) operating in Hospitals & Allied Services sector. Dr. Lal Pathlabs Ltd. key ...

Dr Lal Pathlabs, India’s largest diagnostic chain, posted a 19.3 per cent rise in profit after tax to Rs 98 crore for Q3FY25 on a 10.7 per cent rise in revenue to Rs 597 crore. The Ebitda grew by 9.6 ...

News for Dr. Lal Pathlabs Ltd. Dr Lal PathLabs Q3 Profit Rises 19% to Rs 98 cr Dr Lal PathLabs reports a 19% rise in profit after tax for the third quarter ended December 31, 2024, reaching Rs 98 ...

Dr Lal PathLabs reports a 19% rise in profit after tax for the third quarter ended December 31, 2024, reaching Rs 98 crore. Revenue also increased to Rs 597 crore. New Delhi, Jan 30 (PTI) Dr Lal ...

Diagnostics chain Dr Lal PathLabs, plans to open 15-20 new labs this financial year 2024-25 (FY25). In an interview with CNBC-TV18, CEO Shankha Banerjee discussed the company’s target to maintain ...

Dr Lal Pathlabs Ltd share price was up by 2.87% from the previous closing price of ₹2,681.95. Who are peers of Dr Lal Pathlabs Ltd? The peers of Dr Lal Pathlabs Ltd are Max Healthcare Institute ...